Sugar Editorial Picks
Oct 21, 2008 -
Being a curious creature, I like to compare things. Recently, I decided to focus on cooking oil. I tend to use canola and olive oil when cooking since they're healthy oils, but as I peruse the shelves of oils at the grocery store, there are so many more to choose from.
- 12 Comments
Other Search Results
Oct 29, 2009 -
In the Summer months, I crave cool, crispy raw salad greens, but when cooler temps roll in, I'm all about cooked greens. I often sauté them in a little olive oil with garlic, and they're flavorful, low in calories, and full of vitamins and nutrients. If you've ever wondered just how nutritious they are, I made a little chart so you can find out.
- 11 Comments
Jun 09, 2009 -
When thinking of food as medicine, we have gotten a little reductive. By trying to find the one active ingredient that makes a food healthy, we have forgotten about the food itself. Omega-3 fatty acids found in fish have been found to fight inflammation and reduce depression.
- 7 Comments
Feb 26, 2008 -
I recently bought some grapeseed oil for a new "longevity" recipe I am about to try (if it is any good I will be sure to share it with you). Unpacking my groceries, I was feeling like I got suckered into buying yet another cooking oil that is supposed to help me age gracefully. So I did some research and it looks like I am not such a sucker after all.
- 13 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Lifestyle Changes
- Diagnostic Tests
- Staging Systems
- Surgical Procedures
- Radiation Treatments
- Treatment Options by Stages...
- Chemotherapy Treatments
- Investigative Agents
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Research News:
- About 3,000 nonsmokers die each year of lung cancer resulting from exposure to secondhand smoke, according to a 2006 Surgeon General report.
- Advexin, a genetic therapy that contains the p53 tumor-suppressor gene, is showing promise. A 2006 study in Japan found that out of 13 patients with advanced NSCLC receiving Advexin, 10 had stabilized. Advexin is in Phase II clinical trials for NSCLC.
- Studies are finding that NSCLC tumors in people who never smoked have a much higher rate of epithelial growth-factor receptor (EGFR) mutations.
- 0 Comments
Oct 08, 2008 -
Overview
- Signs and Symptoms
- What Causes It?
- What to Expect at Your Provider's Office
- Treatment
- Special Considerations
- Supporting Research
HEALTH GUIDE REFERENCE FROM A.D.A.M
Low back pain affects 60 - 80% of the adult U.S. population. Low back problems affect the spine's flexibility, stability, and strength, which can cause pain, discomfort, and stiffness.
- 0 Comments
Oct 08, 2008 -
Overview
- Signs and Symptoms
- Causes
- Risk Factors
- Diagnosis
- Preventive Care
- Treatment
- Other Considerations
- Supporting Research
HEALTH GUIDE REFERENCE FROM A.D.A.M
Osteoarthritis (OA) is the most common form of arthritis. It is a joint disease caused by the breakdown of cartilage -- the firm, rubbery tissue that cushions bones at joints.
Healthy cartilage allows bones to glide over one another, and cartilage absorbs energy from the shock of physical movement.
- 0 Comments
Oct 08, 2008 -
Overview
- Signs and Symptoms
- What Causes It?
- Who's Most At Risk?
- What to Expect at Your Provider's Office
- Treatment Options
- Prognosis/Possible Complications
- Following Up
- Supporting Research
HEALTH GUIDE REFERENCE FROM A.D.A.M
Systemic lupus erythematosus (SLE) is the most common form of lupus. Lupus is an autoimmune disorder in which the body harms its own healthy cells and tissues. This leads to inflammation and damage of body tissues in the joints, skin, kidneys, heart, lungs, blood vessels, or the brain.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Dietary Factors
- Prevention
- Diagnosis
- Staging
- Prognosis
- Surgery
- Medications
- Radiation Treatment
- Follow-up Testing
- Treatment for Metastasized ...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In September 2006, the Food and Drug Administration approved panitumumab (Vectibix) for the treatment of patients with colorectal cancer that has spread to other parts of the body following chemotherapy. Like cetuximab (Ertibux), panitumumab targets the epidermal growth factor receptor (EGFR) on cancer cells. Panitumumab is the first new colorectal cancer drug approved since 2004.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Symptoms
- Complications
- Diagnosis
- Treatment
- Lifestyle Changes
- Abdominal Infections
- Encephalopathy
- Ascites
- Bleeding Episodes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In 2007, the Food and Drug Administration approved HepaGram B, an injectable immune globulin that can help prevent recurrence of hepatitis B following liver transplantation.
Primary Biliary Cirrhosis
Primary biliary cirrhosis is an autoimmune liver disease that increases the risk for liver cancer. According to a 2007 study, specific risk factors may help predict which patients with primary biliary cirrhosis are at particularly high risk of developing liver cancer.
- 0 Comments